Introduction
Chronic Myelogenous Leukemia (CML) is a neoplastic disorder of bone marrow progenitor cells that is associated with the presence of the Philadelphia (Ph) t(9;22) chromosome, a reciprocal translocation of c-abl from chromosome 9 to the bcr gene on chromosome 22 (Ben-Neriah et al., 1986; Mes-Masson et al., 1986) . In cells expressing the Ph chromosome, a fusion Bcr-Abl oncoprotein is expressed, producing dysregulated activity of the Abl tyrosine kinase (Samali et al., 1997) . Bcr-Abl is the transforming activity responsible for CML and confers both uncontrolled proliferation and profound cellular resistance to chemotherapeutic drug-induced apoptosis. That Bcr-Abl is sucient for drug resistance has been shown by increased sensitization of CML cell lines to apoptosis after its inhibition (McGahon et al., 1994; Rowley et al., 1996) , and conversely overexpression of Bcr-Abl in Ph 7 cell lines leads to enhanced resistance to drug-induced apoptosis (Amarante-Mendes et al., 1998a,b) . Bcr-Abl induced transformation is initiated by upstream activation of p21 ras and PI3K (Zou and Calame, 1999) , however its downstream targets are incompletely characterized. Recently we demonstrated that the atypical PKCi is required for Bcr-Abl mediated resistance to taxolinduced apoptosis in the CML cell line, K562 (Jamieson et al., 1999; Murray and Fields, 1997) .
Protein kinase C (PKC) is a multigene family of phospholipid-dependent serine/threonine kinases consisting of at least 11 isoforms that are expressed in virtually all cells and tissue types and are involved in regulation of cellular proliferation, dierentiation and apoptosis (Blobe et al., 1996) . The PKC enzyme family can be divided into three subgroups: the calciumdependent or cPKCs (a, b, and g); the novel or nPKCs (d, e, y, and Z); and the atypical or aPKC (x and l/i). Recently, we have shown isotype-speci®c functions for PKCs in the CML K562 cell line; while PKCa induces cellular dierentiation and cytostasis, PKCb II is required for cellular proliferation (Murray et al., 1993; Murray and Fields, 1997) . By contrast, PKCi activation is required for K562 cell survival from taxolinduced apoptosis (Jamieson et al., 1999; Murray and Fields, 1997) . Taxol treatment leads to inducible and sustained activation of PKCi in K562 cells but not in Bcr-Abl-negative HL-60 myeloid leukemia cells (Jamieson et al., 1999) . Furthermore, expression of constitutively active PKCi leads to rescue of K562 cells to taxol-induced apoptosis in the presence of a selective Bcr-Abl inhibitor, AG957 (Jamieson et al., 1999) .
Together, these results demonstrate that PKCi is a relevant downstream kinase required for Bcr-Abl mediated cell survival (Jamieson et al., 1999; Murray and Fields, 1997) . However, the mechanism by which PKCi confers cell survival to taxol is unknown.
The transcription factor NF-kB plays a critical role in host defense by regulating the expression of immune and in¯ammatory genes (Ghosh et al., 1998) . NF-kB is a family of dimeric proteins that share a conserved *300 amino acids within the N-terminal Rel homology domain (RHD), a region that determines dimerization, nuclear localization and binding to kB elements in target genes (Kuriyan and Thanos, 1995; May and Ghosh, 1997) . The NF-kB family consists of ®ve identi®ed mammalian isoforms: p65 (RelA), c-Rel, Rel B, NF-kB1 (p50) and NF-kB2 (p52 or p50B) (Kuriyan and Thanos, 1995; May and Ghosh, 1997) . Of these, RelA and c-RelA are highly transcriptionally-active proteins due to the presence of unique amphipathic alpha helical transactivation domains in their COOH termini . These proteins are primarily targeted to DNA as heterodimers with the NF-kB1 DNA binding subunit. In unstimulated cells, NF-kB complexes are sequestered in the cytoplasm in an inactive form through interaction with a family of inhibitor proteins called IkBs. After stimulation, IkBa is rapidly degraded, exposing nuclear localization signals on NF-kB, resulting in its rapid nuclear translocation (May and . Although NF-kB has been intensely studied for its role in activation of immune response genes (May and , it has also been implicated in cell survival. Cells with inactivated NFkB, by expression of nonproteolyzable IkB inhibitor or through genetic knockout, are more susceptible to apoptosis induced by ligands of the TNF receptor superfamily, chemotherapeutic agents, or DNA-damaging agents (Baichwal and Baeuerle, 1997; Barnes, 1997; Beg and Baltimore, 1996) . The mechanism by which NF-kB confers cell survival is unknown. The observations that TNF-induced apoptosis is enhanced in cells treated in the presence of protein synthesis inhibitors (Beg and Baltimore, 1996; Van Antwerp et al., 1996 argue that NF-kB is protective through its ability to induce expression of anti-apoptosis gene products such as Bcl-X L , IEX-1L or others (Amarante-Mendes et al., 1998a; Van Antwerp et al., 1996 Wooten 1999; Wu et al., 1998) .
Paclitaxel (taxol) is a potent antineoplastic drug with promise in the treatment of a variety of chemotherapyrefractory solid tumors. Taxol is of limited utility in the treatment of CML because of the emergence of resistant clones during later stages of the disease. In this study, we examined the mechanism for PKCimediated resistance to apoptosis in taxol-resistant K562 chronic myelogenous leukemia cells. In contrast to its eects in epithelial-derived cancers (Lee et al., 1997) , and that of the prototypical stimulant, TNF, taxol induces a weak and delayed NF-kB translocation, but robust transcriptional activation of a NF-kB-dependent reporter gene. Inhibition of IkBa degradation either by pretreatment with proteasome inhibitors (MG132 and LLnV), or by overexpression of a dominant-negative IkBa signi®cantly down regulated NF-kB activity and sensitized cells to taxol-induced apoptosis. Transient expression of RelA reversed the inhibitory eect of antisense (PKCi-AS), dominant-negative PKCi (PKCi-KD), dominant-negative IkBa, and the Bcr-Abl inhibitor (AG957) on induction of NF-kB target gene activation and apoptosis. Overexpression of either PKCi wild-type (PKCi-WT) or constitutively active PKCi (PKCi-CA) enhances transcriptional activity of NF-kB and AP-1, and protects K562 cells from apoptosis induced by AG957 and taxol. Surprisingly, taxol activates chimeric GAL4-RelA transactivator in a manner which was further upregulated by expression of PKCi-CA and inhibited by expression of PKCi-KD. Collectively, these results indicate that NF-kB is an important downstream signal of the PKCi-mediated Bcr-Abl pathway and its activity is required for K562 cell survival from taxol-induced apoptosis.
Results

Taxol induces a slow NF-kB-dependent gene activation program
The human chronic myelogenous leukemia cell line, K562, expresses Bcr-Abl and is highly resistant to apoptosis induced by the antineoplastic/microtubule depolymerizing agent, paclitaxel (taxol). For example after exposure to 100 nM taxol, 30% of the K562 cell population is apoptotic after 48 h, whereas 490% of the taxol-sensitive HL-60 cell population is apoptotic within 24 h (Murray and Fields, 1997) . Importantly, we have shown that PKCi is required for K562 cell resistance to taxol-induced apoptosis, as its downregulation by expression of antisense cDNA to PKCi markedly sensitizes these cells to the eects of taxol (Murray and Fields, 1997) . Because PKCi is a regulator of the NF-kB transcription factor through its ability to interact with the IkB kinase complex we examined whether taxol induced the transcriptional response of an NF-kBinducible promoter, IL-8 (Brasier et al., 1998; Vlahopoulos et al., 1999) . For this analysis, K562 cells were co-transfected with a luciferase reporter plasmid driven by the human IL-8 gene promoter (nucleotides 7162 to +44, hIL-8 WT/Luc) and an internal control plasmid constitutively expressing b-gal (pCMV-b Gal) prior to taxol stimulation for various times prior to simultaneous harvest and assay of reporter gene activity. In marked contrast to the behavior of IL-8 CAT reporter genes in taxol-responsive solid tumor lines (Lee et al., 1997) , which were inducible by 24 h, no consistently detectable increase in hIL-8 WT/Luc activity was observed in K562 cells at 24 h. However transcriptional activity was strongly induced at 48 h with an apparent peak at 72 h (143-fold, and 183-fold increase relative to control, respectively-see Figure 1a ). To determine whether K562 cells could rapidly activate NF-kB transcription, a parallel transfection was performed where cells were stimulated with TNFa ( Figure 1b) . We observed that TNF rapidly induced hIL-8 WT/Luc reporter activity with an induction detectable as early as 1 h (55-fold relative to control) and reaching an apparent maximum 6 h (670-fold induction) after stimulation (Figure 1b and Jamaluddin et al., 2000) . To con®rm that taxol activated hIL-8 WT/Luc in an NF-kB-dependent manner, the activity of a promoter containing a site-directed mutation of the NF-kB binding site (hIL-8 Dk/Luc) was tested as control (Brasier et al., 1998; Vlahopoulos et al., 1999) . As seen in Figure 1c (left panel), taxol-inducible activity of the mutant hIL-8 Dk/Luc construct was about 70% of that of the wild-type reporter, whereas TNF-induced no activation of the mutant construct ( Figure 1c, right panel) . These data indicate that taxolinduced IL-8 reporter gene activity is largely, but not completely, NF-kB-dependent.
To determine if the NF-kB binding site was sucient for taxol-dependent activation, K562 cells were transfected with a trimerized IL-8 NF-kB site upstream of a minimal promoter and stimulated with taxol or TNF ( Figure 1d ). Taxol potently induced NF-kBdependent reporter activity much more so than did TNF (taxol produced a 3400-fold induction relative to control). Together, these data indicate that taxol is a potent inducer of NF-kB-dependent transcriptional activity. Because of the distinct kinetics and magnitude of induction by taxol and TNF, the eect of costimulation was determined (Figure 1e ). In this experiment, cells were stimulated for 24 h prior to harvest and assay for luciferase reporter activity. In the presence of both agents, a greater than additive (synergistic) eect was seen than that produced with either agent alone, suggesting taxol and TNF activate hIL-8 WT/Luc through potentially distinct intracellular signaling pathways.
Taxol weakly induces NF-kB translocation and DNA binding
Taxol-induced NF-kB DNA binding activity was assayed by electrophoretic mobility shift assay (EMSA) on sucrose cushion-puri®ed nuclear extracts prepared from K562 cells treated with 100 nM taxol for 24, 48 and 72 h. Figure 2a (left panel) shows the bound complexes in EMSA formed on the duplex oligonucleotide corresponding to region 796 to 769 of the hIL-8 promoter (IL-8 WT) (Brasier et al., 1998; Vlahopoulos et al., 1999) . In nuclear extracts from control cells, strong binding by a single complex (C3) was detected. However, 48 h after stimulation, two taxol-induced complexes (C1 and C2) were induced along with a decrease in the C3 complex. The binding speci®city of these complexes for NF-kB was con®rmed when excess unlabeled wild-type (IL-8 WT) or mutant (IL-8 Dk) oligonucleotide duplexes were included in the DNA binding reaction. As shown in Figure 2a (right panel) IL-8 WT competed speci®cally for the C1 and C2 complexes whereas IL-8 Dk did not interfere with C1/C2 binding. C3 partially competed with the IL-8WT complex indicating that this complex bound NF-kB with lower anity. Because of the weak binding activity of the taxol-inducible C1/C2 complex, we were unable to determine which NF-kB species are present in these complexes by anity or supershifting assays. In contrast to the eects of taxol, TNF (30 ng/ml) was a potent inducer of C1/C2 binding (Figure 2b, upper) . With TNF, the induction of C1/C2 was rapid (15 ± 30 min) and strong enough to be of similar intensity to the abundance of the low anity C3 complex (a lighter exposure is shown). Identity of the inducible NF-kB subunits was determined using a quantitative and speci®c 2-step microanity isolation/Western blot DNA-binding assay (Brasier et al., 1998; Jamaluddin et al., 2000) . For this assay, equal amounts of sucrose cushion-puri®ed nuclear protein from untreated or TNFa-stimulated (15 min) cells were incubated with biotinylated (Bt) duplex oligonucleotides of IL-8 NF-kB binding site, captured on streptavidin agarose beads, washed and NF-kB complexes detected by Western blot (Figure 2b, lower) . We observed constitutive 50 kDa NF-kB1 and to a smaller extent, 65 kDa RelA, binding consistent with our earlier observations of NF-kB cycling in unstimulated cells (Jamaluddin et al., 2000) . Fifteen minutes after TNFa treatment, RelA binding was increased by 2 ± 4-fold. The sequence-speci®c binding of RelA and NF-kB1 was determined by adding a 10-fold excess of non-Bt IL-8 WT duplex in the initial binding reaction, which competed for binding, leading to a loss of detection of binding complexes. By contrast, the non-Bt IL-8 Dk duplex only partially competed for RelA and NF-kB1 binding (Figure 2b , lower). These data indicate that RelA inducibly binds to the IL-8 NF-kB site in K562 cells.
We next determined whether taxol induced IkBa proteolysis by Western blot of cytoplasmic lysates from treated K562 cells. As seen in Figure 2c , IkBa (37 kDa) was abundantly detected in control cells, and a reduction in its steady state abundance was ®rst detectable at 24 h post treatment (23% reduction), and reached over 50% degradation at 48 h. No consistent changes in IkB steady state abundance could be detected at time points taken before 24 h (data not shown). Not surprisingly, TNFa induced a rapid degradation of cytoplasmic IkBa (65% reduction of IkBa protein at 15 min), followed by its resynthesis to control levels at 60 min post-treatment. With both stimuli, C1/C2 binding was inversely related to the degradation of cytoplasmic IkBa (compare Figure 2c with a and b). To determine whether taxol induces NFkB translocation, a Western blot of sucrose cushionpuri®ed nuclear extracts of taxol-treated cells was performed (Figure 2d ). Nuclei from taxol treated cells had an increased level of in 50 kDa NF-kB1 and slight increase in RelA (1.5-fold). Together these data indicate that while taxol is a potent activator of NFkB transcriptional activation, it only weakly activates translocation and DNA binding of NF-kB.
IkBa degradation is required for taxol-induced NF-kB activation and cell survival Since degradation of phosphorylated IkBa by the 26S proteasome is required for TNFa-inducible NF-kB cells were transiently transfected with 4 mg of the hIL-8 WT/Luc reporter plasmid or internal control pCMV-b-gal reporter plasmid and treated with 100 nM taxol. Reporter activity was measured at 0, 24, 48, and 72 h after addition of taxol. All reporter activities were normalized to total protein and data are from a representative experiment presented as normalized luciferase/internal control b-galactosidase activity (X+s.e., n=2 independent transfections, P50.005, student's t-test, with55% sample-to-sample variation). Taxol-induced reporter activity was increased 143-fold at 48 h with a peak activity (183-fold) at 72 h. (b) Kinetics of TNF-induced transcriptional activation of NF-kB. K562 cells were transiently transfected with 4 mg of the hIL-8 WT/Luc reporter plasmid and treated with 30 ng/ml TNFa for the indicated times prior to harvest and assay (X+s.e., n=2 independent transfections, P50.005, student's t-test). TNF inducible luciferase activity is detectable within 1 h and reaches an apparent maximum at 6 h [see also Jamaluddin et al., 2000; Li et al., 1996) ]. (c) NF-kB-dependence of taxol and TNF-induced reporter activity. Wild-type (hIL-8 WT/ Luc) or NF-kB site-mutant hIL-8 Dk/Luc reporter vectors were transfected into K562 cells as in Figure 1a . Upper panel, cells were stimulated with taxol (100 nM, 48 h) prior to harvest and assay for reporter activity. Taxol induced a 32-fold increase in reporter activity over control, which is signi®cantly inhibited in the NF-kB binding mutant. Lower panel, cells were stimulated with TNF (30 ng/ml, 6 h) prior to harvest and assay. TNFa induces a 126-fold increase of reporter activity for hIL-8 WT/Luc, whereas the hIL-8 Dk/Luc was essentially unresponsive (twofold induction). (d) Taxol is a potent activator of NF-kB transcription. A reporter nuclear translocation (Finco and Baldwin, 1995) and cell survival (Beg and Baltimore, 1996) , we examined the role of the proteasome complex in taxol-induced IkBa degradation in mediating cell survival. Figure 3a shows that taxol-induced NF-kB transcriptional activation was blocked by pre-treating cells with proteasomespeci®c inhibitors MG132 (50 mM) and LLnV (50 mM) (Han et al., 1999a) . These data demonstrate the important role of the proteasome in the taxol-induced activation of the NF-kB signaling pathway.
To con®rm the role of NF-kB activation in mediating cell survival, the eect of a dominantnegative NF-kB inhibitor on taxol-induced apoptosis was tested. Stable transfectants of K562 cells constitutively expressing a non-degradable FLAG epitopetagged IkBa containing substitutions of Ser to Ala at amino acids 32 and 36 A)] were selected and tested for resistance to proteolysis by NFkB-activating stimuli. FLAG-IkBa-(S 32/36 A) was highly expressed in unstimulated cells and was inert to proteolysis by stimulation with TNF (30 ng/ml, 15 min; Figure 3b , lower panel), whereas endogenous IkBa was largely degraded under the same conditions in cells expressing empty control vector (pREP-FLAG). Taxol also failed to induce FLAG-IkBa-(S 32/36 A) proteolysis after 48 h treatment ( Figure 3b ). In these cells, taxol-induced NF-kB reporter activity was reduced by 25-fold compared to control cells expressing empty vector (Figure 3c ). Furthermore, expression of FLAG-IkBa-(S 32/36 A) sensitized K562 cells to taxolinduced apoptosis over twofold when compared to the vector control (38% apoptotic cells vs 18% at 72 h, Figure 3d ). These results indicate that IkBa degradation is required for taxol-induced NF-kB activation and cell survival.
PKCi is involved in taxol-induced NF-kB activation and cell survival
Our previous studies demonstrated that inducible PKCi kinase activity is required for the resistance of K562 cells to taxol-induced apoptosis (Jamieson et al., 1999) . To assess whether PKCi mediates cell survival through NF-kB activation, we modulated PKCi expression in K562 cells. K562 cells stably expressing empty vector, constitutively active PKCi (PKCi-CA, containing an alanine to glutamic acid at amino acid 120 substitution in the pseudo-substrate domain), kinase-dead PKCi (PKCi-KD, containing a Lys to Trp substitution at amino acid 274 in the kinase domain) or antisense PKCi (PKCi-AS) were produced and levels of PKCi detected by Western blot ( Figure  4a ) (Bonizzi et al., 1999; Jamieson et al., 1999; Rowley et al., 1996; Wooten 1999) . Both PKCi-WT and PKCi-CA transfectants expressed elevated level of PKCi when compared to empty vector control cells (pREP). In contrast, PKCi-AS cells showed reduced expression of PKCi. Unexpectedly, slightly reduced PKCi levels were observed in PKCi-KD-expressing stable cells was also consistently observed. We speculate that this may be the consequence of an autoregulatory loop where PKCi controls its own expression. To con®rm that the stable transfectants had disrupted PKCi kinase activity, in vitro PKCi IP-kinase assays were performed. PKCi was immunoprecipitated from control and taxol-treated cells and kinase activity measured by its ability to phosphorylate a standard PKC substrate, histone H1 (Jamieson et al., 1999) . To con®rm the speci®city of the IP-kinase assay for PKCi activity, a control experiment was performed in the presence of the immunizing PKCi peptide in the immunoprecipitation. Immunizing peptide abolished PKCi immunprecipitation and inhibited phosphorylation of histone H1 ( Figure 4b ). These data demonstrate that the IP-kinase assay is speci®c for PKCi. Using this assay, we con®rmed that taxol induces PKCi activity by approximately 11.4-fold in empty vector expressing cells ( Figure 4c ). Both unstimulated and taxol-induced kinase activity is reduced in both PKCi-KD and PKCi-AS expressing cells (Figure 4c ). Conversely, PKCi-CA cells contain 2.8-fold elevated PKCi activity in untreated cells that is further stimulated by taxol treatment due to additional contribution of wild-type PKCi in these cells (Figure 4c ).
To determine if NF-kB activation is downstream of PKCi, the hIL-8 WT/Luc reporter plasmid was transiently transfected into the stable transfectants with modulated PKCi activity. Although basal activity was not changed, taxol-induced transcriptional activation of hIL-8 WT/Luc was increased 1.9-fold in PKCi-WT-overexpressed cell line relative to vector control cells (Figure 4d ). Thus, PKCi appears to modulate, but is not sucient to activate, hIL-8 transcription. In contrast, both basal and taxol-inducible hIL-8 WT/Luc reporter activity were blocked in PKCi-AS (96% reduction) and PKCi-KD (99% reduction) expressing cells. These data indicate that PKCi activity is required for taxol-induced NF-kB activation. Western blot analysis was used to determine whether PKCi activity is essential for taxol-and TNF-induced IkBa proteolysis. In unstimulated cells, steady state abundance of IkBa was signi®cantly increased in both PKCi-AS and PKCi-KD expressing cells (Figure 4e , top panel). After either taxol or TNF treatment, steady state levels of IkBa were reduced in control, PKCi-WT and PKCi-CA cells. In contrast, signi®cant inhibition of IkBa degradation was seen in PKCi-AS and -KD expressing cells. These data indicate that PKCi can modulate NFgene containing trimerized hIL-8 NF-kB binding site ligated upstream of a minimal promoter was transfected into K562 cells as in a. Transfectants were stimulated with taxol (100 nM, 60 h) or TNF (30 ng/ml, 6 h) prior to harvest and assay of luciferase reporter activity. Taxol increased reporter activity 3400-fold, while TNF activated reporter activity 750-fold (X+s.e., n=2 independent transfections, P50.005, student's t-test). (e) Synergistic interactions between taxol and TNF. K562 cells were transfected and stimulated with taxol (100 nM), TNF(30 ng/ml) or a combination for 24 h prior to harvest and assay of luciferase reporter activity Figure 1 were subjected to EMSA. Taxol-induced NF-kB complex (C2) is shown at 48 h treatment, whereas C1 and C3 are constitutive complexes. Right panel, Speci®city of NF-kB DNA binding. Nuclear proteins from taxol-treated (48 h) cells were incubated with radiolabeled IL-8/NF-kB probe in the presence of 50-fold molar excess of cold WT IL-8/NF-kB or Dk IL-8/NF-kB as described in Materials and methods. The taxol-induced C2 complex and the constitutive C1 complex competed with the wild-type but not the NF-kB site mutant, indicating sequence-speci®c NF-kB binding activity. (b) Upper, Kinetics of TNFa-induced NF-kB DNA binding activity. Nuclear extracts (10 mg/sample) from TNF-treated cells were analysed by EMSA using duplex a7 32 P-labeled IL-8/NF-kB speci®c probe. C2 complex is induced after 15 min of TNFa treatment; C1 and C3 are constitutive complexes. Lower, Inducible NF-kB components. TNFa-treated (15 min) nuclear extracts were captured on Bt-IL-8 WT duplex in the absence or presence of nonbiotinylated IL-8 wild-type (WT) or IL-8 mutant (Dk) competitors. Bound complexes were examined by Western blot using speci®c RelA and NF-kB1 antibodies. RelA and NF-kB1 abundance were increased by * twofold after TNFa treatment (15 min); binding is speci®cally competed by WT, and weakly by Dk probe, indicating binding preference. (c) Time-course analysis of inducible IkBa proteolysis. Top panel, K562 cells (10 5 cells/ml) were treated with 100 nM taxol for 24, 48, and 72 h. Cytoplasmic proteins were analysed by Western blot with antibody to IkBa. Up to 50% of IkBa was degraded after 48 h of taxol treatment. Bottom panel, K562 cells were treated with TNFa (30 ng/ml) for 0, 15, 30 and 60 min. One hundred mg of cytoplasmic extract was subjected for Western blot analysis using antibodies to IkBa. (d) Taxol-induced NF-kB nuclear translocation. Nuclear proteins from control and taxol-treated samples were subjected for Western blot analysis using antibodies speci®c for 65 kDa RelA and 50 kDa NF-kB1 13% of cells were apoptotic upon taxol treatment, respectively, relative to 25% in control cells (Figure 4f ). Conversely, cell survival was signi®cantly reduced in PKCi-AS and -KD transfectants, in which 43 to 45% of cells were apoptotic after 72 h treatment. Together, these results demonstrate that PKCi kinase activity is required for both NF-kB activation and cell survival.
RelA expression rescues the inhibitory effects of dominant-negative PKCis on taxol-induced NF-kB activation and cell survival
To con®rm the critical role of NF-kB in PKCimediated Bcr-Abl signaling, we ectopically expressed the transcriptionally-active RelA NF-kB subunit. For this purpose, a constitutive expression vector encoding an enhanced green¯uorescent protein (EGFP) tagged full-length 65 kDa RelA was constructed (pCMV-EGFP/RelA) and cotransfected with hIL-8 WT/Luc reporter plasmid into parental K562 cells or K562 stable transfectants expressing PKCi-WT, -CA, -AS, -KD or FLAG-IkBa (S 32/36 A). Controls were identical cells transfected with empty expression vector (pCMV-EGFP). Figure 5a shows that ectopic expression of EGFP/RelA increased basal reporter activity in all stable transfectants when compared with empty vector controls. Interestingly, in cells expressing PKCi-CA, RelA expression signi®cantly increased the basal level of NF-kB target gene reporter activity (18-fold increase over EGFP, Figure 5a ). As shown in Figure 5b , taxolinduced NF-kB transcriptional activity in PKCi stable transfectants was signi®cantly upregulated when EGFP/RelA was transiently expressed (PKCi-WT, fourfold and -CA, sevenfold relative to empty vector cells treated with taxol). PKCi-AS and PKCi-KD had an inhibitory eect on taxol-induced reporter activity, which was restored to that of control cells by overexpression of EGFP/RelA, which increased reporter activity eightfold in PKCi-AS cells and fourfold in PKCi-KD cells (Figure 5b) . As a control, transient expression of RelA in dominant-negative FLAG-IkBa-(S 32/36 A) expressing cells showed an increase in NF-kB reporter activity by threefold compared to cells expressing pCMV-EGFP vector alone (Figure 5c ). These data demonstrate that taxol-induced PKCi activity is upstream of NF-kB transcriptional activation.
To determine whether overexpressing RelA could restore cell survival in K562 cells in which PKCi activity is blocked (PKCi-AS and -KD stable transfectants), either pCMV-EGFP/RelA or pCMV-EGFP plasmids were transiently transfected into these cells prior to taxol exposure. Transiently-transfected cells (those expressing green¯uorescent protein) were assayed for apoptosis by direct¯uorescence microscopy of DAPI staining (Jamieson et al., 1999) . As shown in Figure 5d , transient expression of EGFP/RelA in the control cells signi®cantly reduced the percentage of apoptotic cells from 27 to less than 5%. In cells with reduced PKCi activity, the percentage of cells undergoing apoptosis was 3.5-fold lower with EGFP/RelA expression (for PKCi-AS) and 2.8-fold with EGFP/ RelA expression (for PKCi-KD). These data indicate that RelA rescues cells from taxol-induced apoptosis in the absence of PKCi. Finally, transient EGFP/RelA expression rescued FLAG-IkBa-(S 32/36 A)-expressing cells (with a 3.3-fold reduction in apoptosis relative to EGFP expression alone). These cells are otherwise exquisitively sensitive to taxol with 35 ± 40% of the population undergoing apoptosis (Figure 5e ). Together, these data indicate that NF-kB expression rescues PKCi-de®cient K562 cells from taxol-induced apoptosis.
Taxol-induced NF-kB activation is Bcr-Abl dependent
We showed earlier that Bcr-Abl is required for PKCi activation and taxol resistance (Jamieson et al., 1999) . Therefore, we next asked whether Bcr-Abl is critical for NF-kB activation. K562 cells were transfected with hIL-8 WT/Luc and stimulated with taxol in the absence or presence of the tyrosine kinase inhibitor, AG957. AG957 has been shown to be a selective inhibitor of Bcr-Abl kinase activity that interferes with autophosphorylation and disrupts association with Grb2 and Shc (Ana® et al., 1993; Kaur and Sausville, 1996) . As shown in Figure 6a , inhibition of Bcr-Abl signaling reduces hIL-8 WT/Luc to undetectable levels. Co-expression of PKCi-CA signi®cantly restored reporter activity, which was not further increased by taxol stimulation (compare AG vs AG+Taxol for PKCi-CA cells, Figure 6a ). These data indicate that constitutively active PKCi can rescue NF-kB-dependent transcription in the absence of Bcr-Abl, consistent with its eects on cell survival (Jamieson et al., 1999) . We found that coexpression of both PKCi-CA and EGFP/RelA restored transcriptional activity in BcrAbl-inhibited cells to 85% of that produced in taxol treated cells with active Bcr-Abl (Figure 6b ). These results indicate that expression of both PKCi and EGFP/RelA are required to fully restore NF-kB transcriptional activity in the absence of Bcr-Abl. The potent ability of taxol to stimulate transcriptional activation of NF-kB target genes (Figure 1) , in contrast to its weak ability to induce RelA translocation (Figure  2) , led us to suspect that taxol may function, at least in part, by activating a latent transcriptional activation function of NF-kB. The RelA transactivation domain is contained in two alpha helical segments, TA1 and TA2, located in the COOH-terminal 120 amino acids of RelA (Schmitz et al., 1995) . To speci®cally measure transactivation function of RelA, we constructed a GAL4-RelA expressing plasmid in which a DNA fragment encoding the transactivation domain of RelA (amino acids 255 ± 551) was fused downstream of the DNA binding domain of GAL4 (Li and Brasier, 1996) . Since this molecule lacks the NH 2 -terminal IkB interacting domain, it is a constitutively nuclear transactivator of GAL4 binding sites (UAS/Luc). The eect of taxol on RelA transactivation function was evaluated by co-transfecting K562 cells with GAL4-RelA (255 ± 551), PKCi-CA or -KD expressing plasmids and the UAS/Luc reporter plasmid. In the absence of stimulation, transcriptional activity of GAL4-RelA-dependent UAS/Luc reporter activities was barely detectable above control samples ( Figure  7 ). This was somewhat surprising, as GAL4-RelA produces potent and high levels of UAS reporter activity in epithelial cells (Li and Brasier, 1996; Schmitz et al., 1995) . Upon taxol treatment however, UAS reporter activity was strongly activated in the presence of GAL4-RelA (255 ± 551). This response is dependent upon GAL4-RelA (255 ± 551) since taxol fails to activate UAS reporter activity in the absence of GAL4-RelA (255 ± 551). PKCi regulates the transcriptional activation of GAL4-RelA (255 ± 551) as indicated by the increased transcription in PKCi-CA cells, and its decreased transcriptional activity in PKCi-KD cells. The expression and nuclear localization of GAL4-RelA (255 ± 551) was con®rmed by Western blot analysis and its abundance did not change upon taxol treatment (data not shown). Together, these data demonstrate that taxol induces latent transcriptional activation of RelA through its COOH terminal transactivation domain, accounting for its potent transcriptional activation of NF-kB-dependent reporter genes.
Discussion
The t(9;22) chromosomal translocation found in the human CML cell line, K562, results in expression of the fusion oncoprotein p210 Bcr-Abl which exhibits dysregulated c-Abl tyrosine kinase activity (Ben-Neriah et al., 1986; Mes-Masson et al., 1986) . A large body of evidence indicates that Bcr-Abl is an apoptotic suppressor whose activity confers resistance to apoptosis induced by serum deprivation, irradiation, and chemotherapeutic agents (Cortez et al., 1995 (Cortez et al., , 1996 Jamieson et al., 1999; Murray and Fields, 1997; Samali et al., 1997) . Our previous studies demonstrate that PKCi functions downstream of Bcr-Abl and its activity is required for K562 cell resistance to paclitaxel (taxol)-induced apoptosis (Jamieson et al., 1999; Murray and Fields, 1997) . Although we have demonstrated that taxol upregulates PKCi to suppress apoptosis (Jamieson et al., 1999; Murray and Fields, 1997) , the downstream signaling pathway(s) mediating PKCi-dependent cell survival have not been elucidated. Here we establish the requirement of NF-kB transcriptional activation for PKCi-mediated cell survival. Our data further indicate that the Bcr-Abl/PKCi pathway activates NF-kB transcription by activating RelA at two levels, ®rst by controlling its translocation (via IkB proteolysis) and second through activation of its latent transactivation function.
Taxol is a novel antineoplastic agent with clinical applications in drug-resistant cancers of epithelial origin, including ovarian and breast cancer (Huizing et al., 1995) . Although taxol has promise in the treatment of CML, its clinical utility is limited by drug resistance seen in the later stages of the disease (`blast crisis'), and therefore understanding the mechanisms of cellular resistance to taxol is of therapeutic importance. In responsive cells, taxol-induced cell death is via a classic apoptotic pathway characterized by early membrane destabilization (phosphatidylserinē ipping), and later nuclear PARP cleavage (indicative of caspase 3 activation), nuclear condensation and oligonucleosomal laddering (Blagosklonny et al., 1995 (Blagosklonny et al., , 1996 ; Murray and Fields, 1997) data not shown]. The Figure 7 Taxol activates RelA transcriptional activity independently of changes in NF-kB nuclear translocation. Eect of PKCi and taxol on latent RelA transactivation function. K562 cells were transiently transfected with expression vector for GAL4-RelA (255 ± 551) and GAL4 binding site (UAS)-driven Luc reporter plasmid along with either empty vector control (pREP), PKCi-CA and PKCi-KD expression plasmids. Cells were either treated with vehicle control or taxol (100 nM for 72 h) as indicated. Inducible luciferase activity is seen only in the presence of GAL4-RelA expression and taxol stimulation. PKCi-CA coexpression further upregulated GAL4-RelA dependent transcription and PKCi-KD signi®cantly inhibited RelA dependent transcription mechanism of taxol-induced cell death has been partly characterized. Taxol blocks cell cycle progression in the G2/M phase of the cell cycle through a mechanism involving accumulation of p21WAF, and initiates apoptosis (at least in part) through Raf-1-dependent phosphorylation and inactivation of Bcl-2 (Blagosklonny et al., 1995 Moos and Fitzpatrick, 1998; Torres and Horwitz, 1998) . Bcr-Abl initiates a protective response to taxol by in¯uencing the expression or activity of downstream anti-apoptotic proteins including Bcl-2, Bcl-X L , cytochrome c and perhaps others (Amarante-Mendes et al., 1998a; Samali et al., 1997; Van Antwerp et al., 1996) . Recently we demonstrated that PKCi is a downstream mediator of Bcr-Abl signaling and that its kinase activity is required for cell survival to taxol (Jamieson et al., 1999; Murray and Fields, 1997) . The downstream targets of the Bcr-Abl/PKCi signaling cascade are unknown. Here we demonstrate that NF-kB is activated by taxol through a PKCi-dependent pathway. Our data indicate that PKCi is upstream of NF-kB because PKCi kinase activity peaks 12 ± 24 h after taxol exposure (Jamieson et al., 1999) , preceding IkBa proteolysis and NF-kB activation (Figures 1 and 2) . Secondly, inhibition of IkBa proteolysis blocks the ability of PKCi to confer cell survival. Finally NF-kB expression rescues PKCi-de®cient cells from taxolmediated apoptosis. These observations agree with other reports that PKCi is involved in activation of NF-kB and that expression of antisense PKCi blocked both basal and NGF-stimulated NF-kB activity and cell survival Wooten 1999) .
Although cell survival after exposure to TNF-, ionizing radiation or DNA-damaging agents is believed to be due to the activation of NF-kB transcriptional activity (Granville et al., 1998) , its role in drug-induced apoptosis has not been well established (Sonenshein 1997; Van Antwerp et al., 1996 . Our data in K562 cells are consistent with that of others showing that taxol induces NF-kB translocation in murine macrophages and that NF-kB mediates taxol-induced IL-8 gene expression in ovarian cancer cells (Das and White, 1997; Hwang and Ding, 1995; Lee et al., 1998; Perera et al., 1996) . However, we note that NF-kB activation was observed only in the ovarian cancer cell lines that were sensitive to taxol-induced cell death, but not in the resistant clones (Lee et al., 1997) . Our data surprisingly indicate that in taxol-resistant K562 cells, NF-kB is not only activated following taxol exposure, but its activation is required for cell survival. This conclusion is based on the following observations: (1) Taxol is a potent activator of NF-kB-dependent gene transcription; (2) Inhibition of NF-kB activity by blocking IkBa degradation signi®cantly sensitizes cells to taxol-induced apoptosis; (3) NF-kB rescues PKCi-de®cient cells from taxol-induced apoptosis. The requirement for NF-kB in preventing apoptosis is probably through its ability to activate transcription of anti-apoptotic`survival' proteins, including Bcl-X L , IEX-1L and perhaps other genes yet to be identi®ed (Perera et al., 1996; Reuther et al., 1998; Wang et al., 1996) .
Our ®ndings demonstrate that taxol signi®cantly enhances latent transcriptional activity of GAL4-RelA (Figure 7) . These data indicate that in addition to weakly inducing NF-kB nuclear translocation, taxol may also induce post-translational modi®cation of RelA through PKCi kinase activity. It has been shown previously that NF-kB family members are nuclear phosphoproteins whose phosphorylation may in¯uence DNA binding or transactivation activity (Naumann and Scheidereit, 1994; Schmitz et al., 1995; Wang and Baldwin, 1998) . Speci®cally, NF-kB activating agents induce RelA/p65 phosphorylation in its COOHterminal transactivation domain through p38/MAPK (Vanden Berghe et al., 1998), PKAc (Zhong et al., 1997) , Casein Kinase II-like (Bird et al., 1997) , Ras/ Akt (Madrid et al., 2000) and as yet unidenti®ed IKKassociated kinases (Sakurai et al., 1999) . Further, our present data suggest a role for PKCi in mediating postranslational modi®cation of RelA, since the activation of GAL4-RelA is independent of nuclear translocation, and taxol-induced NF-kB transactivation comes coincidently after the peak of PKCi activation. Consistent with our observations, others have shown that overexpression of a dominantnegative PKCi abolishes TNFa-induced NF-kB-dependent transcription in NIH3T3 and Jurkat cells (Bonizzi et al., 1999) . We note that earlier studies have shown that PKCi can directly bind the IKK complex (Bonizzi et al., 1999; Wooten 1999 ). It will be of interest to determine whether phosphorylation of the RelA transactivation domain is required to mediate PKCi-induced NF-kB transcription, and if so, whether this is directly mediated by PKCi or an another IKK associated kinase.
In addition to activating NF-kB-dependent antiapoptosis signaling, taxol also triggers signaling pathways which are independent of IKK-NF-kB (Lee et al., 1998) . Several observations that support this statement include: (1) inhibition of NF-kB with the dominantnegative IkBa mutant does not completely block taxolinduced transcription of the IL-8 promoter ( Figure 3) ; (2) mutation of the NF-kB binding site on the IL-8 promoter does not completely block taxol-induced transcriptional activity ( Figure 1c) ; (3) taxol induces both NF-kB and AP-1-dependent promoter activity (preliminary results, data not shown); (4) in cells overexpressing wild-type-or constitutively active PKCi, AP-1 as well as NF-kB-dependent reporter activity is dramatically upregulated (Figure 1 and data not shown). Therefore, we conclude that taxol activates at least two partially overlapping-signaling pathways downstream of PKCi: the PKCi-dependent NF-kB transactivation and the PKCi-dependent transcriptional activation of AP-1. Although taxol activates AP-1, this signaling pathway is not sucient for cell survival because selective modulation of NF-kB signaling by agents that do not interfere with AP-1 (expression of IkBa- (S 32/36 A) and ectopic expression of NF-kB/RelA) has a profound in¯uence on cell survival.
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It is important to note that Bcr-Abl kinase expression alone does not result in constitutive PKCi or NF-kB activation, but is required for taxol inducible PKCi activation (Jamieson et al., 1999) , explaining why GAL4-RelA is not consistutively active in K562 cells. Our data are in accord with others that have shown that NF-kB activation is required for Bcr-Ablmediated oncogenesis (Reuther et al., 1998) . Earlier, we showed that inhibition of Bcr-Abl kinase activity by a speci®c Bcr-Abl kinase inhibitor suppresses taxolinduced PKCi activation and cell survival, and that taxol fails to induce PKCi activity in the Bcr-Ablnegative HL-60 cell line (Jamieson et al., 1999) . In the present study, we provide evidence that taxol-induced NF-kB activation is also Bcr-Abl dependent because taxol-induced NF-kB transactivation can be blocked by AG957 (Figures 6 and 7 ). An interesting ®nding in our study is that the kinetics of taxol-induced NF-kB activation are relatively slower than that induced by TNF treatment in K562 cells. The mechanism for TNF inducible NF-kB activation have been extensively investigated and are due to a`protein recruitment' mechanism. The`protein recruitment' is a rapid response pathway where the preformed IkB kinase (IKK) complex associates with the cytoplasmic domain of the liganded TNF receptor and becomes activated through autophosphorylation within minutes of stimulation (reviewed in Maniatis, 1997) . By contrast, the activation of IKK through the Bcr-Abl/PKCi pathway is slower. The signaling intermediates are not known, but one rate-limiting step appears to be the activation of PKCi itself. Kinetic studies by Jamieson have shown that PKCi may require 6 ± 12 h after taxol stimulation for induction of maximal kinase activity (Jamieson et al., 1999) . The PKCi-IKK relationship will require additional study, and our present data does not indicate whether PKCi directly acts on the IKK complex or through other intermediates. Together, these observations indicate that the NF-kB activation by taxol is a downstream event from Bcr-Abl, and is a parallel intracellular signaling pathway functioning synergistically with the TNF pathway. Our data further suggests that both Bcr-Abl and PKCi are required for NF-kB dependent cell survival. Although overexpression of RelA partially rescues the eect of the Bcr-Abl inhibitor on transcription, coexpression of activated PKCi is required for maximal RelA activation ( Figure  6 ). We suggest that the requirement for PKCi is because it is essential to activate overexpressed RelA.
In summary, we demonstrate that taxol induces an upregulation of NF-kB translocation and transactivation that has profound eects on cell survival. Taxolinduced NF-kB activation appears to be mediated through a Bcr-Abl/PKCi signaling pathway converging on the IKK signalsome (schematically diagrammed in Figure 8 ). Because transcriptional activity of NF-kB is required for cell survival, NF-kB may mediate survival by inducing expression of yet-to-be-identi®ed antiapoptotic gene products. The ability to sensitize resistant leukemia cells to the eect of taxol by antagonizing the NF-kB or PKCi pathway may have important implications for the treatment of chemotherapy-resistant CML.
Materials and methods
Cell culture and treatment
Human K562 erythroleukemia cells were obtained from ATCC (Manassas, VA, USA) and maintained in RPMI-1640 medium (Gibco, BRL) supplemented with 10% (v/v) fetal bovine serum, 10 mM glutamine, 100 IU penicillin/ml, 100 mg streptomycin/ml and 20 mM HEPES [pH 7.5] as described (Jamieson et al., 1999) . Recombinant human TNFa (Calbiochem, San Diego, CA, USA) was added to growth medium at a ®nal concentration of 30 ng/ml. Cells at a density of 2610 5 cells/ml were treated with 100 nM paclitaxel (taxol, Calbiochem) for the indicated times. Where indicated the Bcr-Abl tyrosine kinase inhibitor tyrphostin AG957 (30 ± 100 mM) (Calbiochem) was added to K562 cell cultures prior to taxol treatment (Jamieson et al., 1999) . Speci®c proteasome inhibitors N-carbobenzoxy-L-leucyl-L-leucyl-norvalinal (LLnV, 50 mM, Sigma, St. Louis, MO, USA) and Z-Leu-LeuLeucinal (MG132, 50 mM from Sigma) were added to cell cultures 30 min prior to TNFa or taxol treatment.
Plasmids
Construction of the wild-type and mutant human IL-8 promoter driven luciferase reporter plasmids (7162/+44 hIL-8 WT/Luc and 7162/+44 hIL-8 Dk/Luc) and multimeric NF-kB binding sites upstream of a minimal promoter were previously described (Brasier et al., 1998; Vlahopoulos et al., 1999) . The phosphorylation-defective (dominantnegative) mutant IkBa-(S 32/36 A) was created by substitution of amino acid residues serine 32 and 36 to alanine at its Nterminus by PCR-mutagenesis and cloned into a eukaryotic expression vector derived from the episomal plasmid pREP (In Vitrogen) previously modi®ed to contain an NH 2 -terminal FLAG epitope tag. The full-length wild-type PKCi (PKCi-WT) and PKCi in the antisense orientation (PKCi-AS) were generated by ligating the full-length human PKCi open reading frame in the sense and antisense orientation respectively into the pREP vector (Murray and Fields, 1997) . Constitutively active PKCi (PKCi-CA) was generated by PCR-mediated site-directed mutagenesis and ampli®cation of a fragment containing an alanine to glutamine (A 120 E) substitution within the pseudosubstrate domain of human PKCi as described previously (Jamieson et al., 1999) . Kinase dead PKCi (PKCi-KD) was created using a two-step PCR mutagenesis method to introduce a (K 274 W) substitution at the ATP binding site. The EGFP/RelA expression plasmid was constructed with a PCR fragment encoding the fulllength human RelA open reading frame inserted into a pEGFP mammalian expression plasmid (Clontech, Palo Alto, CA, USA) downstream of the EGFP coding sequence at BamHI and XbaI restriction sites. The GAL4-RelA (255 ± 551) expression plasmid containing the human RelA transactivating domain (amino acid 255 ± 551) fused downstream of GAL4 DNA binding domain (amino acids 1 ± 149) in the psG424 vector as previously described (Li and Brasier, 1996) . All plasmids were puri®ed by ion exchange chromatography (Qiagen) and cloned inserts sequenced to con®rm authenticity.
Cell transfection and reporter assays
Transient transfection of the IL-8/Luc reporter plasmid was carried out using DMRIE-C reagent (Gibco, BRL) as described by the manufacturer. Brie¯y, for each transfection 4 ± 10 mg of plasmid DNA was resuspended into 0.5 ml OPTI-MEM 1 I reduced serum medium (Gibco, BRL), mixed with an equal volume of medium containing 10 ml DMRIE-C Reagent and incubated at room temperature for 60 min to allow formation of the lipid-DNA complex. Logarithmically growing K562 cells (2610 6 cells) were centrifuged, resuspended in 0.5 ml reduced serum medium and added into the lipid-DNA complex and incubated at 378C in a CO 2 incubator for 5 h; after which, growth medium (containing 10% FBS) was added and incubated overnight. Hygromycin (200 mg/ml) (Gibco, BRL) was added to select and maintain stable K562 transfectants. Transfectants were screened for expression of exogenous IkBa or PKCi proteins by immunoblot analysis described previously (Jamieson et al., 1999) . For reporter assays, cells were harvested at the indicated time points and washed two times with cold PBS. Cytoplasmic lysates were prepared and independently measured for luciferase and b-galactosidase activity (Promega, Madison, WI, USA) as described Figure 8 Proposed signaling pathways involved in PKCi-mediated NF-kB activation and cell survival. A schematic diagram showing hypothetical mechanism for taxol-induced NF-kB activation and cell survival mediated through Bcr-Abl activity. Taxol induced activation of PKCi activity is required for cell survival. PKCi inducibly associates with the IkB kinase (IKK) complex and activates NF-kB through a pathway that is mediated through obligate IkBa degradation. In addition, the taxol/Bcr-Abl/PKCi signals activate latent NF-kB transactivation. Once in the nucleus, activated NF-kB mediates the expression of anti-apoptotic genes previously (Brasier et al., 1998 ). Luciferase reporter activity was then normalized to the internal control of bgalactosidase activity to control for sample-to-sample variations in transfection eciency.
PKCi immunoprecipitation (IP) -kinase assays
PKCi IP-kinase assays were performed as described previously (Jamieson et al., 1999) . Brie¯y, K562 cell transfectants were lysed in modi®ed lysis buer (MLB) (20 mM Tris, pH, 7.5, 10% glycerol, 1% NP-40, 10 mM EDTA, 150 mM NaCl). Cell lysates (200 mg) were precleared for 1 h with Protein A Sepharose beads (50 ml, 50% slurry). NH 2 -terminal Anti PKCi antibody (2 mg, Santa Cruz sc-727) was then incubated with pre-cleared cell lysates for a further 1 h. Protein A Sepharose (50 ml, 50% slurry) was added to above mixture and incubated at 48C for 10 min. The immunoprecititates were washed three times with 1 ml of MLB and once with 1 ml of kinase assay buer and then subjected to the kinase assay. Immunoprecipitates were resuspended in kinase buer containing, 10 mg of histone substrate, 10 mM ATP, and 10 mCi of [g-32 P]ATP and incubated at room temperature for 30 min, separated by SDS-polyacrylamide gel electrophoresis and kinase activity detected by autoradiography. For peptide competition assay, the anti PKCi antibody was pre-incubated for 1 h with speci®c blocking peptide (sc-727P) prior to the addition of pre-cleared extract.
Preparation of cytoplasmic extracts
K562 cells were washed twice with cold PBS and resuspended in hypotonic Buer A [50 mM HEPES (pH 7.4), 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 1 mg/ml pepstatin A, 1 mg/ml leupeptin, 10 mg/ml soybean trypsin inhibitor, 10 mg/ml aprotinin, and 0.5% Nonidet P-40]. After 10 min on ice, the lysates were centrifuged at 4000 g for 4 min at 48C and the supernatants (cytoplasmic proteins) were collected.
Preparation of nuclear extracts
For puri®cation of nuclei, nuclear pellets were resuspended in hypotonic Buer A containing 2 M sucrose and centrifuged at 12 000 g for 30 min at 48C. The resultant nuclear pellets were incubated in Buer C [Buer A with 10% (v/v) glycerol and 400 mM KCl], vortexing frequently for 30 min at 48C. After centrifugation at 15 000 g for 5 min at 48C, the supernatant containing nuclear extracts was collected. Cytoplasmic and nuclear extracts were normalized for protein concentrations by the Bradford assay using bovine serum albumin as a standard (Bio-Rad, Hercules, CA, USA).
Electrophoretic Mobility Shift Assay (EMSA)
Nuclear extract was prepared from control and TNFa-or taxol-treated K562 cells at indicated times. Duplex oligonucleotides used in the EMSA corresponded to 796 to 769 nucleotides of the IL-8 gene promoter (mutations in the known NF-kB binding sites are underlined) (Vlahopoulos et al., 1999) . IL-8 wild type (WT): GATCCATCAGTTGCA-AATCGTGGAATTTCCTCTA; GTAGTCAACGTTTAG-CACCTTAAAGGAGATCTAG; IL-8Dk: GATCCATCA-GTTGCAAATCGTTTAATTTAATCTA; GTAGTCAAC-GTTTAGCAAATTAAATTAGATCTAG.
DNA-binding reactions were carried out in a mixture of 20 mg of nuclear proteins, 12 mM HEPES (pH 7.9), 40 mM KCl, 120 mM NaCl, 0.2 mM EDTA, 0.2 mM EGTA, 0.4 mM dithiothreitol, 0.5 mM PMSF, 8% glycerol, 2 mg of poly-(dAdT), and 20 000 c.p.m. of a-32 P-labeled double-stranded IL-8 WT probe in a total volume of 20 ml. The reaction mixture was incubated on ice for 1 h and then fractionated by 6% nondenaturing polyacrylamide gel electrophoresis (PAGE) containing 2% glycerol. Gels were dried and subjected to autoradiography using Kodak X-AR ®lm at 7708C. Competition was performed by the addition of a 100-fold molar excess of nonradioactive double-stranded oligonucleotide competitor at the time of addition of the radioactive probe.
Microaffinity purification assays
Analysis of NF-kB binding subunits was performed using a two-step biotinylated DNA-streptavidin capture assay as described previously (Jamaluddin et al., 2000) . Brie¯y, equal amount of nuclear proteins (*250 mg) from control and TNFa-treated cells were incubated with 40 pmol of duplex wild-type biotinlyated-IL-8 fragment (Bt-IL-8) (Genosys, The Woodlands, TX, USA) and 10 mg of poly (dA-dT) for 1 h at 48C in 500 ml binding buer. Proteins bound to Bt-IL-8 were captured by addition of 50 ml of pre-washed streptavidin-agarose beads [50% (v/v) slurry, Pierce] and incubated for additional 20 min at 48C. After washing with the binding buer, bound NF-kB proteins were eluted by SDS ± PAGE loading buer for Western blot analysis. For competition, a 10-fold excess of nonbiotinylated duplex oligonucleotides was included in the initial binding reaction (Han et al., 1999b; Jamaluddin et al., 2000) .
Western blot analysis
K562 cellular proteins were fractionated by SDS ± PAGE (10% polyacrylamide) and transferred onto polyvinylidene di¯uoride membranes (Millipore, Bedford, MA, USA) using electrical transfer at 55 V in 1x CAPS buer at room temperature for 1 h (Garofalo et al., 1996) . The anitypuri®ed rabbit polyclonal antibodies to RelA (A, sc-109), NF-kB1 (NLS, sc-114), IkBa (c-21, sc-371) (Santa Cruz Biotech, Santa Cruz, CA, USA) or a mouse monoclonal antibody to PKCi (Transduction Labs/Pharmingen) was used. Speci®c NF-kB and PKCi proteins were detected with horseradish peroxidase-coupled donkey anti-rabbit IgG antibody (1 : 5000 dilution) in the ECL enhanced chemiluminescence assay (Amersham Life Sciences) as described previously (Garofalo et al., 1996) .
Apoptosis assay
Apoptosis was assessed by the presence of apoptotic bodies as described previously (Jamieson et al., 1999) . Brie¯y, for detection of apoptotic bodies, 1610 5 cells were ®xed and permeablized with 1% paraformaldehyde phosphate-buered saline (Sigma) for 15 min at 378C, stained with 4',6-diamidino-2-phenylindole (DAPI) for 5 min, and observed under phase-¯uorescence optics. These morphological manifestations of apoptosis correlate directly with the apoptotic DNA fragmentation induced by taxol and provide a convenient method to quantitate the apoptotic response (Granville et al., 1998; Jamieson et al., 1999) . For each treatment, a minimum of 500 cells was scored for the presence of apoptotic bodies.
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